MARKET

IMA

IMA

ImageneBio
NASDAQ
5.54
-0.08
-1.42%
Closed 16:18 06/15 EDT
OPEN
5.80
PREV CLOSE
5.62
HIGH
5.92
LOW
5.54
VOLUME
22.01K
TURNOVER
0
52 WEEK HIGH
18.00
52 WEEK LOW
3.940
MARKET CAP
62.49M
P/E (TTM)
-1.0077
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMA last week (0608-0612)?
Weekly Report · 23h ago
Weekly Report: what happened at IMA last week (0601-0605)?
Weekly Report · 06/08 10:20
Weekly Report: what happened at IMA last week (0525-0529)?
Weekly Report · 06/01 10:25
ImageneBio CEO presents at Jefferies Global Healthcare Conference
PUBT · 05/27 20:31
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
Barchart · 05/27 15:30
Weekly Report: what happened at IMA last week (0518-0522)?
Weekly Report · 05/25 10:28
Weekly Report: what happened at IMA last week (0511-0515)?
Weekly Report · 05/18 10:28
Analysts Offer Insights on Healthcare Companies: ImageneBio (IMA) and Capricor Therapeutics (CAPR)
TipRanks · 05/11 14:00
More
About IMA
ImageneBio, Inc., formerly Ikena Oncology, Inc., is a clinical-stage biotechnology company. The Company is focused on developing disease-modifying treatments for immunological/autoimmune and inflammatory (I&I) diseases. The Company develops differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The Company’s lead asset is IMG-007, a novel non-depleting anti-OX40 mAb bioengineered with Fc N297A mutations to abolish antibody-dependent cellular cytotoxicity (ADCC). IMG-007 is designed to specifically bind to OX40 on activated T cells and block the interaction between OX40 and OX40L without killing the T cells. The Company is conducting a Phase 2b clinical trial of IMG-007 in patients with moderate-to-severe atopic dermatitis.

Webull offers ImageneBio Inc stock information, including NASDAQ: IMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMA stock methods without spending real money on the virtual paper trading platform.